Get Premium to unlock powerful stock data
Regnum Corp logo

Regnum Corp

$ 0.22 0 (0%) 08:08 PM EST
P/E:
At Loss
P/B:
0
Market Cap:
$ 4.98M
Enterprise V:
$ 5.00M
Volume:
-
Avg Vol (2M):
3.86K
Volume:
-
Market Cap $:
4.98M
PE Ratio:
At Loss
Avg Vol (2-Month):
3.86K
Enterprise Value $:
5.00M
PB Ratio:
0
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Business Description

Regnum Corp
NAICS : 512110 SIC : 7812
600 Third Avenue, 19th Floor, New York, NY, USA, 10016
Description
Regnum Corp is focused on developing and commercializing therapeutics that treat rare and infectious diseases. It develops Leronlimab (PRO 140), a CCR5 antagonist to treat multi-drug resistant HIV infection.
Name Current Vs Industry Vs History
Cash-To-Debt 0.99
Equity-to-Asset -0.26
Debt-to-Equity -3.97
Debt-to-EBITDA -4.1
Interest Coverage No Debt
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score 0
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year Revenue Growth Rate -100

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 31.37
9-Day RSI 30.22
14-Day RSI 31.26
6-1 Month Momentum % 357.14
12-1 Month Momentum % -59.75

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.8
Quick Ratio 0.8
Cash Ratio 0.8

Dividend & Buy Back

Name Current Vs Industry Vs History
Name Current Vs Industry Vs History
ROA % -89.25
ROIC % -24.35
Years of Profitability over Past 10-Year 2

GF Value Rank

Name Current Vs Industry Vs History
Price-to-Owner-Earnings 216.9
EV-to-EBIT -13.78
EV-to-EBITDA -13.78
EV-to-FCF -518.25
Earnings Yield (Greenblatt) % -7.26

Financials

RGMP's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with OTCPK:RGMP

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Performance
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0
EPS (TTM) ($) -0.01
Beta 0
Volatility % 320.82
14-Day RSI 31.26
14-Day ATR ($) 0.015697
20-Day SMA ($) 0.274685
12-1 Month Momentum % -59.75
52-Week Range ($) 0.07 - 1.43
Shares Outstanding (Mil) 22.95

Piotroski F-Score Details

Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Regnum Corp Filings

Document Form Filing Date
No Filing Data

Headlines

See More